2023
DOI: 10.1016/j.matpr.2023.02.170
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and characterization of niosomal suspension of Valsartan for the treatment of hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…In-vitro drug release: The in-vitro drug release study is carried out in two medium: Phosphate buffer and gastrointestinal pH medium 59,60 .…”
Section: Semmentioning
confidence: 99%
“…In-vitro drug release: The in-vitro drug release study is carried out in two medium: Phosphate buffer and gastrointestinal pH medium 59,60 .…”
Section: Semmentioning
confidence: 99%